Development of novel darunavir amorphous solid dispersions with mesoporous carriers

被引:13
作者
Zolotov, Sergey A. [1 ]
Demina, Natalia B. [2 ]
Zolotova, Anna S. [1 ]
Shevlyagina, Natalia V. [3 ]
Buzanov, Grigorii A. [4 ]
Retivov, Vasilii M. [5 ]
Kozhukhova, Evgeniia I. [5 ]
Zakhoda, Oleg Y. [1 ]
Dain, Igor A. [1 ]
Filatov, Andrei R. [1 ]
Cheremisin, Alexander M. [1 ]
机构
[1] Amedart LLC, Moscow, Russia
[2] Sechenov First Moscow State Med Univ, Inst Pharm, Dept Pharmaceut Technol, Moscow, Russia
[3] Gamaleya Fed Res Ctr Epidemiol & Microbiol, Moscow, Russia
[4] NRC Kurchatov Inst, Inst Chem Reagents & High Purity Chem Subst, Moscow, Russia
[5] Russian Acad Sci, Karnakov Inst Gen & Inorgan Chem, Moscow, Russia
关键词
Amorphous solid dispersion; Differential scanning calorimetry; Dissolution testing; X-ray powder diffraction; Darunavir; Mesoporous silica; Magnesium aluminum silicate;
D O I
10.1016/j.ejps.2021.105700
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this work was to compare mesopomus carriers based on silica and magnesium aluminosilicate in the amorphous solid dispersion production. Darunavir has been selected as an active pharmaceutical ingredient that is classified as a Class 2 BCS substance and exists in two commercially available forms: crystalline ethanolate and amorphous. In the course of the study, the conditions for the preparation of amorphous samples with the selected carriers were evaluated within the framework of the most common methods for obtaining solid dispersions - hot-melt extrusion, solvent wetting, and spray drying. It was determined that the obtained dispersion properties almost completely repeat the properties of the corresponding carriers. The resulting dispersions were examined in a dissolution test and the best ones was used to formulate tablets, which were studied in an in vitro dissolution test with the original Prezista. The proposed tablet formulation showed improved dissolution compared to the original one. It was also found that silica supports have a greater positive contribution to darunavir dissolution - both ethanolate or amorphous forms.
引用
收藏
页数:13
相关论文
共 50 条
[41]   Understanding the Tendency of Amorphous Solid Dispersions to Undergo Amorphous–Amorphous Phase Separation in the Presence of Absorbed Moisture [J].
Alfred C. F. Rumondor ;
Håkan Wikström ;
Bernard Van Eerdenbrugh ;
Lynne S. Taylor .
AAPS PharmSciTech, 2011, 12 :1209-1219
[42]   Investigating the Influence of Processing Conditions on Dissolution and Physical Stability of Solid Dispersions with Fenofibrate and Mesoporous Silica [J].
Baumgartner, Ana ;
Dobaj, Nina ;
Planinsek, Odon .
PHARMACEUTICS, 2024, 16 (05)
[43]   In vivo performance of amorphous solid dispersions based on water-insoluble versus water-soluble carriers: Fenofibrate case study [J].
Schver, Giovanna C. R. M. ;
Novakovic, Jasmina ;
Lee, Ping I. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2025, 671
[44]   Understanding the Tendency of Amorphous Solid Dispersions to Undergo Amorphous-Amorphous Phase Separation in the Presence of Absorbed Moisture [J].
Rumondor, Alfred C. F. ;
Wikstroem, Hakan ;
Van Eerdenbrugh, Bernard ;
Taylor, Lynne S. .
AAPS PHARMSCITECH, 2011, 12 (04) :1209-1219
[45]   Evaluation on the Drug-Polymer Mixing Status in Amorphous Solid Dispersions at the Early Stage Formulation and Process Development [J].
Ma, Hua ;
Choi, Duk Soon ;
Zhang, Yu-E ;
Tian, Hung ;
Shah, Navnit ;
Chokshi, Hitesh P. .
JOURNAL OF PHARMACEUTICAL INNOVATION, 2013, 8 (03) :163-174
[46]   Quality-by-design in hot melt extrusion based amorphous solid dispersions: An industrial perspective on product development [J].
Butreddy, Arun ;
Bandari, Suresh ;
Repka, Michael A. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 158
[47]   Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution [J].
Hitesh S. Purohit ;
Lynne S. Taylor .
Pharmaceutical Research, 2017, 34 :2842-2861
[48]   Interplay of Degradation, Dissolution and Stabilization of Clarithromycin and Its Amorphous Solid Dispersions [J].
Pereira, Junia M. ;
Mejia-Ariza, Raquel ;
Ilevbare, Grace A. ;
McGettigan, Heather E. ;
Sriranganathan, Nammalwar ;
Taylor, Lynne S. ;
Davis, Richey M. ;
Edgar, Kevin J. .
MOLECULAR PHARMACEUTICS, 2013, 10 (12) :4640-4653
[49]   The interplay of poorly soluble drugs in dissolution from amorphous solid dispersions [J].
Kokott, Marcel ;
Breitkreutz, Jorg ;
Wiedey, Raphael .
INTERNATIONAL JOURNAL OF PHARMACEUTICS-X, 2024, 7
[50]   Physical stability of API/polymer-blend amorphous solid dispersions [J].
Lehmkemper, Kristin ;
Kyeremateng, Samuel O. ;
Bartels, Mareike ;
Degenhardt, Matthias ;
Sadowski, Gabriele .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2018, 124 :147-157